COLON DETOX- docusate sodium and sennosides tablet 
OPMX LLC

----------

Colon Detox

Drug Facts

Active Ingredients

Purpose

Active ingredients (in each tablet)Purpose
Docusate sodium 50 mgStool softner
Sennosides 8.6 mgLaxative

Uses

For relief of occasional constipation (irregularity). This product generally produces bowel movement in 6 to 12 hours.

Warnings

Do not use

  • if you are presently taking mineral oil, unless directed by a doctor.
  • laxative products should not be used for a period longer than 1 week unless directed by a doctor.

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomitting
  • noticed a sudden change in bowel habits that lasts over 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or failure to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding

ask a health professional before use.

Keep out of reach of children

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

agestarting dosemaximum dose
adults and children 12 years of age and older2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
children under 2 yearsask a doctorask a doctor

Other information

Inactive ingredients

croscarmellose sodium, colloidal silicon dioxide, dicalcium phosphate, D&C Yellow #10, FD&C Yellow #6, hypromellose, microcrystalline cellulose, magnesium stearate, maltodextrin, polyethylene glycol, stearic acid, titanium dioxide.

Questions or comments?

Call toll free 1-844-832-1138 Monday through Friday 9AM-5PM EST or https://www.opmx.us

Colon Detox

Colon Detox

Colon Cleanser

Helps Lose Belly Fat

Stool Softener

60 Tablets

CD

COLON DETOX 
docusate sodium and sennosides tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69729-151
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
Product Characteristics
ColorredScoreno score
ShapeROUNDSize10mm
FlavorImprint Code P
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69729-151-601 in 1 CARTON11/16/2023
160 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00711/16/2023
Labeler - OPMX LLC (029918743)
Establishment
NameAddressID/FEIBusiness Operations
ELYSIUM PHARMACEUTICALS LIMITED915664486manufacture(69729-151) , label(69729-151) , pack(69729-151)

Revised: 2/2024
Document Id: 11ee012a-51b2-9afd-e063-6294a90a2a5f
Set id: 0a4d3265-080c-d2ed-e063-6394a90adbee
Version: 2
Effective Time: 20240221
 
OPMX LLC